Cannabis Clinical Trials

By Veterinary Practice News Editors The AKC Canine Health Foundation (CHF), which has funded more than $2 million for canine epilepsy research, launched an initiative in 2017 to further understand the most common neurological disorder that affects pure- and mixed-breed dogs. Improved treatments are urgently needed, especially for dogs with drug-resistant epilepsy or where side […]

by

SEATTLE, WA–(Marketwired – Sep 14, 2017) – CFN Media Group (“CannabisFN”), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article examining CURE Pharmaceutical’s (OTCQB: CURR) recently developed CureDots™, a more humane and effective technique for administering drugs to animals. Animals are commonly used when testing drugs, […]

by

NEW YORK, September 13, 2017 /PRNewswire/ — The upward trajectory of the cannabis industry has garnered comparisons to the Internet boom of the early 2000s, as North American sales are on pace to record a compound annual growth rate of 25 percent through 2021, according to Arcview Market Research (1). These comparisons are certainly attention-grabbing, […]

by

[ACCESSWIRE] Jensen will Oversee Company’s New Drug Application (NDA) Process for Prana DENVER, CO / ACCESSWIRE / September 13, 2017 / United Cannabis Corporation (OTCQB: CNAB) (the “Company” or “United Cannabis”) today announced that Murray Jensen has joined the Company’s Medical Advisory Board and is tasked with overseeing the Company’s Investigational New Drug (IND) application […]

by

Bill Boerum’s statement to the Sonoma City Council’s special meeting, a Community Workshop on Cannabis, on Monday night: “Though not representing any specific organization, I have had 10 years of healthcare and hospital governance experience on the local, regional, and statewide levels. My other disclaimer is that I am not now, nor have I ever been a […]

by

NEW YORK, September 12, 2017 /PRNewswire/ — With leading recent estimates clocking the 2016 North American legal cannabis market between $6.7 and $7.2 billion, the only thing more impressive about the industry is the growth projections. Research estimates a whopping compound annual sales growth rate of 25 percent through 2021. This stupendous growth, driven by […]

by

Zelda Therapeutics Ltd (ASX:ZLD) is making significant progress with its medical cannabis research program in Chile. The company has already established a focus on autism, eczema and insomnia. Zelda has now engaged the services of an experienced team of clinicians and scientists to help manage its clinical trials. Harry Karelis, executive chairman, commented: “We welcome […]

by

Blockchain, the technology that powers digital currencies like Bitcoin, will make a cannabis-sector debut in Australia with the help of Canadian cannabis app developer Global Cannabis. The company has announced that it will launch an Australian subsidiary called Global Cannabis Apps (Australia), and has tasked the new company with the development of blockchain software for […]

by

NEW YORK, September 12, 2017 /PRNewswire/ — Known as America’s most expensive disease, with an estimated cost to the U.S. economy of $236 billion in 2016, Alzheimer’s disease (AD) affects more than 5.3 million Americans. Over the next 20 years, the number of those afflicted with the disease is expected to double. The forecast is […]

by

The country’s health administration is scrambling to deal with the onslaught and the rush is having unexpected side effects. Namely, Health Canada is increasing licenses for Access to Cannabis for Medical Purposes Regulations (ACMPR) licences. This shift is positioning several Canadian RD and testing companies at the forefront of the greatest growth industry in the […]

by